Singapore, 5th October 2018. Most people with asthma rely on inhaled asthma medication to control their symptoms. Inhaler devices are available as either dry powder inhaler (DPI) or pressurised metered dose inhaler (pMDI). Both devices require...
Read more
Database-derived measures of asthma control was predictive of asthma treatment response and future asthma exacerbation. This study validates the usage of database records for future studies investigating the efficacy of treatments and predicting...
Read more
A study in The Journal of Allergy and Clinical Immunology: In Practice found the majority of surveyed people with hay fever were not picking optimal over-the-counter medications to treat their symptoms.
Read more
Southampton, 12th December, 2017. A study led by the University of Southampton has found that people who continue to get problems from their asthma, despite receiving standard treatment, experience an improved quality of life when they are taught...
Read more
Singapore, 13th November, 2017. Chronic obstructive pulmonary disease (COPD) is an important public health challenge as it is a major cause of chronic morbidity and the 4th leading cause of death worldwide1.
Read more
Treatment with NRT during a brief, 4-week, follow-up period does not appear to put patients at risk of cardiovascular disease. However, at 52 weeks, there was an increase in cardiovascular events for patients prescribed NRT, compared with those...
Read more
Dose-dependent reduction in asthma exacerbations for patients treated with extrafine-particle inhaled corticosteroids in an adult UK asthma population; a result not seen in patients treated with fine-particle ICS.
Read more